Skip to main content

Table 3 Responses and outcomes of patients in the oseltamivir group and control group

From: Platelet desialylation is a novel mechanism and a therapeutic target in thrombocytopenia during sepsis: an open-label, multicenter, randomized controlled trial

Variables

Control (n = 52)

Oseltamivir (n = 54)

P value

Platelet response rate, % (n)

65.4 (34)

83.3 (45)

0.045

Platelet recovery time (day)

7 (5, 10)

5 (4, 6)

0.003

Platelet transfusion (apheresis unit)

1.35 ± 1.98

0.676 ± 1.36

0.044

Bleeding (%)

9 (17.3)

11 (20.4)

0.805

28-day mortality (%)

22 (42.3)

19 (35.2)

0.550